Managing Partner, Rho Capital Partners and Rho Ventures
President and CEO, Onyx Pharmaceuticals
President and CEO, Millennium: The Takeda Oncology Company
Founder, Avalon Ventures
Founder, Gilt Groupe
Founder and CEO, Noble Environmental Technologies
Co-Founder and CEO, 23andMe
Co-Founder and CEO, Tableau Software
|
|
| Entry | Author | Date | Location | |
|---|---|---|---|---|
| FDA OKs Changes in Santarus Heart Study | Bruce V. Bigelow | 08/04/11 | San Diego | |
| Halozyme Licensing Deal Valued at $63M | Bruce V. Bigelow | 06/08/11 | San Diego | |
| Page 1 of 1 | ||||